Hector Chinoy

12.5k total citations
169 papers, 3.6k citations indexed

About

Hector Chinoy is a scholar working on Epidemiology, Rheumatology and Immunology. According to data from OpenAlex, Hector Chinoy has authored 169 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Epidemiology, 64 papers in Rheumatology and 56 papers in Immunology. Recurrent topics in Hector Chinoy's work include Inflammatory Myopathies and Dermatomyositis (113 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Celiac Disease Research and Management (29 papers). Hector Chinoy is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (113 papers), Immunodeficiency and Autoimmune Disorders (30 papers) and Celiac Disease Research and Management (29 papers). Hector Chinoy collaborates with scholars based in United Kingdom, United States and Australia. Hector Chinoy's co-authors include Robert G. Cooper, James B Lilleker, William Ollier, Neil McHugh, Noreen Fertig, Meghna Jani, Zoë Betteridge, C.E.M. Griffiths, Richard B. Warren and Harsha Gunawardena and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Hector Chinoy

159 papers receiving 3.5k citations

Peers

Hector Chinoy
Lisa Christopher‐Stine United States
Norberto Ortego‐Centeno Spain
Keith S. Kanik United States
Alessandro Mathieu Italy
Yiannis Ioannou United Kingdom
Monique Hinchcliff United States
Robert Spiera United States
Alan Friedman United States
Floranne C. Ernste United States
Patrick Gordon United Kingdom
Lisa Christopher‐Stine United States
Hector Chinoy
Citations per year, relative to Hector Chinoy Hector Chinoy (= 1×) peers Lisa Christopher‐Stine

Countries citing papers authored by Hector Chinoy

Since Specialization
Citations

This map shows the geographic impact of Hector Chinoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hector Chinoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hector Chinoy more than expected).

Fields of papers citing papers by Hector Chinoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hector Chinoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hector Chinoy. The network helps show where Hector Chinoy may publish in the future.

Co-authorship network of co-authors of Hector Chinoy

This figure shows the co-authorship network connecting the top 25 collaborators of Hector Chinoy. A scholar is included among the top collaborators of Hector Chinoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hector Chinoy. Hector Chinoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2024). Clinical trial eligibility of a real-world connective tissue disease cohort: Results from the LEAP cohort. Seminars in Arthritis and Rheumatism. 67. 152463–152463. 1 indexed citations
2.
Ammori, Basil J., et al.. (2024). Changes in Serum Urate Levels after Bariatric Surgery in Patients with Obesity: An Observational Study. Obesity Surgery. 34(5). 1737–1741. 3 indexed citations
3.
Lamb, Janine A., et al.. (2024). The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations. Lara D. Veeken. 63(12). 3255–3262. 5 indexed citations
4.
Christopher‐Stine, Lisa, Hector Chinoy, Namita Goyal, et al.. (2024). The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms. The Journal of Rheumatology. 51(12). 1198–1207. 1 indexed citations
5.
Santos, C. Sieiro, Elena Nikiphorou, Chih‐Wei Tseng, et al.. (2024). Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study. Rheumatology International. 44(5). 805–817. 2 indexed citations
6.
7.
Gupta, Latika, et al.. (2023). Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases. Lara D. Veeken. 63(5). 1206–1216. 12 indexed citations
8.
Muehlensiepen, Felix, Yuriy Ignatyev, Christoph Fiehn, et al.. (2023). Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey. Rheumatology International. 43(10). 1925–1934. 4 indexed citations
9.
Cordel, N., F. Jouen, Janine A. Lamb, et al.. (2022). Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study. Lara D. Veeken. 62(4). 1711–1715. 5 indexed citations
10.
Reynolds, John A., Ariane L. Herrick, Sahena Haque, et al.. (2022). Determinants of health-related quality of life across the spectrum of connective tissue diseases using latent profile analysis: results from the LEAP cohort. Lara D. Veeken. 62(8). 2673–2682. 4 indexed citations
11.
Al‐Janabi, Ali, Amy Foulkes, H.J.A. Hunter, et al.. (2022). The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. British Journal of Dermatology. 188(4). 542–551. 2 indexed citations
12.
Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(11). 5483–5483. 4 indexed citations
13.
Reynolds, John A., Tracy A. Briggs, Gillian Rice, et al.. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy. 21(1). 147–147. 19 indexed citations
14.
Betteridge, Zoë, Hector Chinoy, Jiří Vencovský, et al.. (2019). Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis. Lara D. Veeken. 59(5). 1026–1030. 13 indexed citations
15.
Tansley, Sarah, Zoë Betteridge, Hui Lu, et al.. (2019). The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients. Lara D. Veeken. 59(7). 1626–1631. 15 indexed citations
16.
Rothwell, Simon, et al.. (2018). Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis. Arthritis Research & Therapy. 20(1). 117–117. 16 indexed citations
17.
Jani, Meghna, William G Dixon, & Hector Chinoy. (2017). Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far. Lara D. Veeken. 57(11). 1896–1907. 44 indexed citations
18.
Tansley, Sarah, Zoë Betteridge, Harsha Gunawardena, et al.. (2012). Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 Autoantibodies.. UCL Discovery (University College London). 1 indexed citations
19.
Betteridge, Zoë, Hector Chinoy, Jiří Vencovský, RG Cooper, & Neil McHugh. (2011). Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients. Lara D. Veeken. 50. 105–106. 2 indexed citations
20.
Chinoy, Hector, Fiona Salway, Noreen Fertig, et al.. (2005). The UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC): In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype rather than by myositis sub type.. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Christopher‐Stine Breakdown of academic impact, for papers by Norberto Ortego‐Centeno Breakdown of academic impact, for papers by Keith S. Kanik Breakdown of academic impact, for papers by Alessandro Mathieu Breakdown of academic impact, for papers by Yiannis Ioannou Breakdown of academic impact, for papers by Monique Hinchcliff Breakdown of academic impact, for papers by Robert Spiera Breakdown of academic impact, for papers by Alan Friedman Breakdown of academic impact, for papers by Floranne C. Ernste Breakdown of academic impact, for papers by Patrick Gordon
Rankless by CCL
2026